Corrigendum: Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer (Annals of Oncology (2014) 25 (592–598) DOI: 10.1093/annonc/mdt543)
- Baselga, J.
- Manikhas, A.
- Cortés, J.
- Llombart, A.
- Roman, L.
- Semiglazov, V.F.
- Byakhov, M.
- Lokanatha, D.
- Forenza, S.
- Goldfarb, R.H.
- Matera, J.
- Azarnia, N.
- Hudis, C.A.
- Rozencweig, M.
ISSN: 1569-8041, 0923-7534
Argitalpen urtea: 2019
Alea: 30
Zenbakia: 6
Orrialdeak: 1017
Mota: Hutsen zuzenketa